Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients

被引：28

作者：

Kiayias, JA ^{[1
]}

Vlachou, ED ^{[1
]}

Theodosopoulou, E ^{[1
]}

Lakka-Papadodima, E ^{[1
]}

机构：

[1] Henry Dunant Hosp, Dept Endocrinol & Metab, Athens, Greece

来源：

DIABETES CARE | 2002年 / 25卷 / 07期

关键词：

D O I：

10.2337/diacare.25.7.1251

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1251 / 1252

页数：2

共 8 条

[1]

Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006

[2] Hepatic failure in a patient taking rosiglitazone [J].

Forman, LM ;

Simmons, DA ;

Diamond, RH .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :118-121

[3] Liver failure in a patient treated with long-term rosiglitazone therapy [J].

Gouda, HE ;

Khan, A ;

Schwartz, J ;

Cohen, RI .

AMERICAN JOURNAL OF MEDICINE, 2001, 111 (07) :584-585

[4]

Jones N, 2001, DIABETOLOGIA, V44, pA235

[5]

Matthews DR, 1998, DIABETIC MED, V15, P297, DOI 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO

[6]

2-N

[7] Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49) [J].

Turner, RC ;

Cull, CA ;

Frighi, V ;

Holman, RR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (21) :2005-2012

[8] The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin - A multicenter, randomized, double-blind, placebo-controlled trial [J].

Yale, JF ;

Valiquett, TR ;

Ghazzi, MN ;

Owens-Grillo, JK ;

Whitcomb, RW ;

Foyt, HL .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) :737-745

← 1 →